Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Delamanid 100 mg BID + OBR	161
Overall Study	STARTED	Delamanid 200 mg BID + OBR	160
Overall Study	STARTED	Placebo + OBR	160
Overall Study	Modified Intent-to-Treat (MITT)	Delamanid 100 mg BID + OBR	141
Overall Study	Modified Intent-to-Treat (MITT)	Delamanid 200 mg BID + OBR	136
Overall Study	Modified Intent-to-Treat (MITT)	Placebo + OBR	125
Overall Study	MITT (Solid Culture)	Delamanid 100 mg BID + OBR	119
Overall Study	MITT (Solid Culture)	Delamanid 200 mg BID + OBR	115
Overall Study	MITT (Solid Culture)	Placebo + OBR	113
Overall Study	COMPLETED	Delamanid 100 mg BID + OBR	143
Overall Study	COMPLETED	Delamanid 200 mg BID + OBR	146
Overall Study	COMPLETED	Placebo + OBR	145
Overall Study	NOT COMPLETED	Delamanid 100 mg BID + OBR	18
Overall Study	NOT COMPLETED	Delamanid 200 mg BID + OBR	14
Overall Study	NOT COMPLETED	Placebo + OBR	15

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00685360/flow